Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 308

1.

Clinical molecular imaging with positron emission tomography.

Saleem A, Charnley N, Price P.

Eur J Cancer. 2006 Aug;42(12):1720-7. Epub 2006 Jun 22. Review.

PMID:
16797972
[PubMed - indexed for MEDLINE]
2.

(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.

Vallabhajosula S.

Semin Nucl Med. 2007 Nov;37(6):400-19. Review.

PMID:
17920348
[PubMed - indexed for MEDLINE]
3.

Molecular imaging of proliferation in vivo: positron emission tomography with [18F]fluorothymidine.

Buck AK, Herrmann K, Shen C, Dechow T, Schwaiger M, Wester HJ.

Methods. 2009 Jun;48(2):205-15. doi: 10.1016/j.ymeth.2009.03.009. Epub 2009 Mar 24.

PMID:
19318128
[PubMed - indexed for MEDLINE]
4.

Assessment of recurrent colorectal cancer following 5-fluorouracil chemotherapy using both 18FDG and 18FLT PET.

Francis DL, Visvikis D, Costa DC, Croasdale I, Arulampalam TH, Luthra SK, Taylor I, Ell PJ.

Eur J Nucl Med Mol Imaging. 2004 Jun;31(6):928. Epub 2004 Mar 18. No abstract available.

PMID:
15034675
[PubMed - indexed for MEDLINE]
5.

Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases.

Pantaleo MA, Nannini M, Lopci E, Castellucci P, Maleddu A, Lodi F, Nanni C, Allegri V, Astorino M, Brandi G, Di Battista M, Boschi S, Fanti S, Biasco G.

Int J Oncol. 2008 Sep;33(3):443-52.

PMID:
18695872
[PubMed - indexed for MEDLINE]
6.

Positron emission tomography imaging of tumor response after photodynamic therapy.

Berard V, Lecomte R, van Lier JE.

J Environ Pathol Toxicol Oncol. 2006;25(1-2):239-49. Review.

PMID:
16566721
[PubMed - indexed for MEDLINE]
7.

The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.

Bang S, Chung HW, Park SW, Chung JB, Yun M, Lee JD, Song SY.

J Clin Gastroenterol. 2006 Nov-Dec;40(10):923-9.

PMID:
17063113
[PubMed - indexed for MEDLINE]
8.

[Positron emission tomography in the management of cervix cancer patients].

Bonardel G, Chargari C, Gontier E, Bauduceau O, Soret M, Dechaud C, Fayolle M, Foehrenbach H.

Cancer Radiother. 2009 Oct;13(6-7):490-8. doi: 10.1016/j.canrad.2009.06.016. Epub 2009 Aug 20. Review. French.

PMID:
19699130
[PubMed - indexed for MEDLINE]
9.

The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.

Chowdhury FU, Bradley KM, Gleeson FV.

Clin Radiol. 2008 Dec;63(12):1297-309. doi: 10.1016/j.crad.2008.05.010. Epub 2008 Aug 21. Review.

PMID:
18996259
[PubMed - indexed for MEDLINE]
10.

Positron emission tomography: clinical applications in oncology. Part 1.

Kumar R, Nadig MR, Chauhan A.

Expert Rev Anticancer Ther. 2005 Dec;5(6):1079-94. Review.

PMID:
16336099
[PubMed - indexed for MEDLINE]
11.

Clinical applications of positron emission tomography/computed tomography treatment planning.

Macapinlac HA.

Semin Nucl Med. 2008 Mar;38(2):137-40. doi: 10.1053/j.semnuclmed.2007.11.005. Review.

PMID:
18243849
[PubMed - indexed for MEDLINE]
12.

Cancer drug development using glucose metabolism radiopharmaceuticals.

Sun YY, Chen Y.

Curr Pharm Des. 2009;15(9):983-7.

PMID:
19275662
[PubMed - indexed for MEDLINE]
13.

[Positron emission tomography and evaluation of response to targeted therapies].

Gauthier H.

Bull Cancer. 2009 Nov;96(11):1087-97. doi: 10.1684/bdc.2009.0971. Review. French.

PMID:
19875353
[PubMed - indexed for MEDLINE]
14.

Positron emission tomography for modeling pathophysiological processes in vivo.

Hendrikse NH, Luurtsema G, van der Veldt AA, Lubberink M.

Curr Opin Drug Discov Devel. 2008 Sep;11(5):717-25. Review.

PMID:
18729023
[PubMed - indexed for MEDLINE]
15.

Imaging cellular proliferation during chemo-radiotherapy: a pilot study of serial 18F-FLT positron emission tomography/computed tomography imaging for non-small-cell lung cancer.

Everitt S, Hicks RJ, Ball D, Kron T, Schneider-Kolsky M, Walter T, Binns D, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1098-104. doi: 10.1016/j.ijrobp.2008.12.039. Epub 2009 Apr 20.

PMID:
19386444
[PubMed - indexed for MEDLINE]
16.

Molecular positron emission tomography and PET/CT imaging in urological malignancies.

Powles T, Murray I, Brock C, Oliver T, Avril N.

Eur Urol. 2007 Jun;51(6):1511-20; discussion 1520-1. Epub 2007 Jan 23. Review.

PMID:
17275167
[PubMed - indexed for MEDLINE]
17.

[Evaluation of therapies in oncology by positron emission tomography: towards therapeutical personalization].

Bonardel G, Vedrine L, Aupee O, Gontier E, Le Garlantezec P, Soret M, Foehrenbach H.

Bull Cancer. 2009 Feb;96(2):213-26. doi: 10.1684/bdc.2008.0816. Review. French.

PMID:
19258228
[PubMed - indexed for MEDLINE]
18.

Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.

de Geus-Oei LF, van der Heijden HF, Corstens FH, Oyen WJ.

Cancer. 2007 Oct 15;110(8):1654-64. Review.

PMID:
17879371
[PubMed - indexed for MEDLINE]
Free Article
19.

18F-fluorodeoxyglucose PET/CT in cancer imaging.

Kayani I, Groves AM.

Clin Med. 2006 May-Jun;6(3):240-4. Review. No abstract available.

PMID:
16826854
[PubMed - indexed for MEDLINE]
20.

What does positron emission tomography offer oncology?

Anderson H, Price P.

Eur J Cancer. 2000 Oct;36(16):2028-35. Review.

PMID:
11044638
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk